Shanghai Pharmaceuticals Correlations

S1R Stock  EUR 1.38  0.02  1.43%   
The current 90-days correlation between Shanghai Pharmaceuticals and Carsales is 0.21 (i.e., Modest diversification). The correlation of Shanghai Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Shanghai Pharmaceuticals Correlation With Market

Good diversification

The correlation between Shanghai Pharmaceuticals Holdi and DJI is -0.13 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Pharmaceuticals Holdi and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Shanghai Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shanghai Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shanghai Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shanghai Pharmaceuticals Holding to buy it.

Moving together with Shanghai Stock

  0.89X2S1 SINOPHARM GROUP 15ONPairCorr
  0.7GGG GUDANG GARAMPairCorr

Moving against Shanghai Stock

  0.78VOW3 Volkswagen AG VZOPairCorr
  0.769NPA NIPPON PROLOGIS REITPairCorr
  0.690S2 UNITED URBAN INVPairCorr
  0.56ABG AmerisourceBergenPairCorr
  0.41CLH Cardinal HealthPairCorr
  0.33K9R KENEDIX OFFICE INVPairCorr
  0.8KPR Klpierre SAPairCorr
  0.8LLD2 Lloyds Banking GroupPairCorr
  0.744AB AbbVie IncPairCorr
  0.68BRYN Berkshire HathawayPairCorr
  0.61QBE QBE INSURGROUPPairCorr
  0.55BMW Bayerische Motoren WerkePairCorr
  0.52SES SES SAPairCorr
  0.49CL4A H World Group Earnings Call This WeekPairCorr
  0.4559V NAGOYA RAILROADPairCorr
  0.44TOH Toho CoPairCorr
  0.41BAS BASF SEPairCorr
  0.37HCM Hitachi ConstructionPairCorr
  0.3547M MedMiraPairCorr
  0.33GNV Angang SteelPairCorr
  0.83PKY1 Polski Koncern NaftowyPairCorr
  0.72HCW WelltowerPairCorr
  0.72DTE Deutsche TelekomPairCorr
  0.72HPI2 RCS MediaGroup SpAPairCorr
  0.71GOB Compagnie de SaintPairCorr
  0.65QBE QBE Insurance GroupPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
GRUSL4
CH5CUD
PN1SL4
CH5WN6
CH5PN1
PN1WN6
  
High negative correlations   
GRUWN6
CUDSL4
SL4WN6
9E7SL4
GRU9E7
CH5RHRD

Risk-Adjusted Indicators

There is a big difference between Shanghai Stock performing well and Shanghai Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Shanghai Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Shanghai Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Shanghai Pharmaceuticals Corporate Management

Elected by the shareholders, the Shanghai Pharmaceuticals' board of directors comprises two types of representatives: Shanghai Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Pharmaceuticals' management team and ensure that shareholders' interests are well served. Shanghai Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jun ZhouChairman of the Board, Non-Executive DirectorProfile
Dawei LiuVice President Secretary of the BoardProfile
Haoliang GuVice PresidentProfile
Liang HongIndependent Non-Executive DirectorProfile
Ying KeDirector CenterProfile
Yong ZhaoVice PresidentProfile
Tao ZhongBoard VPProfile